A Phase 2, Double-Blind, Multiple-Dose Escalation Study to Evaluate NKTR-118 (Oral PEG-Naloxol) in Patients With Opioid-Induced Constipation (OIC)

Clinical trial NCT00600119 · COMPLETED

Trial details

NCT number: NCT00600119
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Induced Constipation (OIC)

Start date: 2007-12-01
Primary completion: 2009-03-01
Enrollment: 207

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.